Durable benefits, but no improvements in overall survival: what can we learn from CheckMate 238 after 9 years of follow-up? (PubMed, Transl Cancer Res) - Sep 12, 2026 - No abstract available
Journal • Melanoma • Oncology • Solid Tumor
|
|
Anna Spreafico; Carlos Diego Holanda Lopes; Daniel V Araujo
|